Business
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Hi, what are you looking for?
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Mylan offered Perrigo shareholders $75 plus 2.3 Mylan shares per Perrigo share, for a total of $35.6 billion. Perrigo Company (NYSE:PRGO; TASE:PRGO) board of...
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
Kenalog® Spray annual sales were approximately $16 million according to IMS Health.
The Perrigo stock weight in the TA-25 (derivatives) is 9.8%, second only to TEVA (10.5%).